🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,315 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8513252

Pyrazole derivatives and their use as positive allosteric modulators of metabotropic gluta

Addex Pharma, S.A. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

Almirall, S.A. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501803

Garcinia derivative, its preparing method and medicinal use

CHINA PHARMACEUTICAL UNIVERSITY · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8497290

Thiocolchicine derivatives, method of making and methods of use thereof

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8492399

3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor anta

Theravance, Inc. · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8492403

Bicyclic derivatives as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8492397

Aminopyridine derivatives having Aurora A selective inhibitory action

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8486965

Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer

Takeda Pharmaceutical Company Limited · Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481569

Iminopyridine derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8475764

Labelled adrenomedullin derivatives and their use for imaging and therapy

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Tue Jul 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8470859

Iminopyridine derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8466290

STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient

Pharmadesign, Inc. · Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461348

Heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8461154

Methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8454946

N-maleimidyl polymer derivatives

Nektar Therapeutics · Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450323

Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4

Takeda Pharmaceutical Company Limited · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8450341

Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibi

Almirall, S.A. · Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445694

Hydrazonopyrazole derivatives and their use as therapeutics

Dermira (Canada), Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445509

Fused heterocyclic derivatives and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8440692

Hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents

China Medical University · Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8435504

Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

Nektar Therapeutics · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8436187

1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivativ

Takeda Pharmaceutical Company Limited · Granted Tue May 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431570

Methods of utilizing arylpiperazine derivatives

REVIVA PHARMACEUTICALS, INC. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431556

C-21-keto lupane derivatives preparation and use thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted